Loading stock data…
Globe Life Inc (GL)
$179.25-0.06 (-0.03%)
After Hours$180.50+1.25 (+0.70%)· Last close Jun 29
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Globe Life Inc. in the Financial Services sector is trading at $179.25 with a market capitalization of $13.0B. Wall Street consensus targets $177.36 (11 analysts), implying a -1.1% move over the next 12 months. The stock is currently near its 52-week high of $181.15, remaining 24.7% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.56B↑ | $1.52B↑ | $1.51B↑ | $1.48B | $1.48B |
| Gross Profit | — | — | — | — | — |
| Operating Income | $365.84M↓ | $367.05M↓ | $513.24M↑ | $348.18M↓ | $351.07M |
| Net Income | $270.53M↑ | $266.08M↓ | $387.84M↑ | $252.75M↓ | $254.56M |
Peer Comparison
JPMBACGS
Fundamentals
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$13.04B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.64%
ROE
Elite ROE. Management converts capital into profit efficiently.
19.35%
Volume
Today's trading volume
875,305
Recent News
Globe Life (GL): Buy, Sell, or Hold Post Q1 Earnings?
Over the past six months, Globe Life has been a great trade, beating the S&P 500 by 19.4%. Its stock price has climbed to $178.90, representing a healthy 26.2% increase. This run-up might have investors contemplating their next move.
How Investors May Respond To Globe Life (GL) Executive Stock Sale Amid Strong 2026 Sales Growth Outlook
In June 2026, Globe Life Inc. disclosed that executive Rebecca E. Zorn exercised 2,000 stock options and sold 2,000 common shares at prices between US$169.70 and US$170.41, while analysts highlighted the insurer’s resilient sales outlook, including an expected 6.3% sales growth rate for 2026 and a favorable Zacks Rank #2. Despite a recent quarter that missed EPS and book value per share estimates, Globe Life has been repeatedly cited as a top sales-growth name, underscoring analyst...
Life Insurance Stocks Q1 Results: Benchmarking Globe Life (NYSE:GL)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at life insurance stocks, starting with Globe Life (NYSE:GL).
Zacks.com featured highlights CACI International, Globe Life and Knight-Swift Transportation Holdings
CACI International, Globe Life and Knight-Swift Transportation Holdings have been highlighted in this Screen of The Week article.
3 Sales Growth Stocks to Bet on as Markets Remain Resilient
CACI, GL and KNX stand out as sales-growth stocks as resilient markets lean on earnings, AI optimism and a supportive economy.